| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer | Jan 30, 2024 | Buy | $3.90 | 40,999 | 159,949 | 216,564 | Jan 31, 2024, 06:29 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer | Jan 31, 2024 | Buy | $4.00 | 27,460 | 109,752 | 244,024 | Jan 31, 2024, 06:29 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer | Jan 29, 2024 | Buy | $3.71 | 31,541 | 117,036 | 175,565 | Jan 31, 2024, 06:29 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer | Dec 08, 2022 | Buy | $2.10 | 55,250 | 115,804 | 144,024 | Dec 12, 2022, 08:00 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Mar 09, 2021 | Sale | $16.61 | 17,017 | 282,569 | 98,774 | Mar 11, 2021, 05:51 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Mar 10, 2021 | Sale | $35.09 | 2,983 | 104,676 | 88,774 | Mar 11, 2021, 05:51 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Feb 24, 2021 | Sale | $18.74 | 20,000 | 374,792 | 98,774 | Feb 26, 2021, 04:50 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Feb 11, 2021 | Option Exercise | $19.34 | 2,892 | 55,923 | 90,220 | Feb 16, 2021, 05:10 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Feb 08, 2021 | Option Exercise | $10.49 | 14,519 | 152,356 | 99,980 | Feb 10, 2021, 07:25 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Feb 09, 2021 | Sale | $35.21 | 5,963 | 209,939 | 90,704 | Feb 10, 2021, 07:25 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Feb 10, 2021 | Sale | $35.28 | 1,930 | 68,097 | 88,774 | Feb 10, 2021, 07:25 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Feb 02, 2021 | Option Exercise | $3.24 | 13,281 | 43,030 | 88,774 | Feb 04, 2021, 05:42 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Feb 02, 2021 | Sale | $18.91 | 6,456 | 122,090 | 92,052 | Feb 04, 2021, 05:40 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Feb 03, 2021 | Sale | $35.00 | 100 | 3,500 | 88,874 | Feb 04, 2021, 05:40 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Jan 27, 2021 | Sale | $17.82 | 20,000 | 356,314 | 85,493 | Jan 29, 2021, 05:22 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Jan 22, 2021 | Sale | $14.49 | 6,240 | 90,400 | 79,563 | Jan 26, 2021, 07:29 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Jan 25, 2021 | Sale | $35.29 | 1,300 | 45,877 | 76,093 | Jan 26, 2021, 07:29 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Jan 26, 2021 | Sale | $35.15 | 600 | 21,090 | 75,493 | Jan 26, 2021, 07:29 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | CEO | Aug 18, 2020 | Option Exercise | $5.98 | 54,159 | 324,039 | 79,644 | Aug 19, 2020, 04:15 PM | |
| ATNM | Actinium Pharmaceuticals, Inc. | TRAVERSA SERGIO | Director | Apr 14, 2016 | Buy | $2.02 | 2,000 | 4,040 | 2,000 | Apr 18, 2016, 05:24 PM | |
| ATNM | Actinium Pharmaceuticals, Inc. | TRAVERSA SERGIO | Director | Apr 15, 2016 | Buy | $2.02 | 1,000 | 2,020 | 3,000 | Apr 18, 2016, 05:24 PM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer | Dec 15, 2015 | Buy | $3.05 | 18,970 | 57,792 | 339,322 | Dec 17, 2015, 09:36 AM | |
| RLMD | RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer | Dec 14, 2015 | Buy | $2.97 | 30 | 89 | 320,352 | Dec 16, 2015, 04:25 PM | |
| ATNM | Actinium Pharmaceuticals, Inc. | TRAVERSA SERGIO | Interim CFO | Aug 08, 2013 | Option Exercise | $3.60 | 10,000 | 36,000 | 0 | Dec 24, 2013, 03:41 PM |
Menu